-
Meta meets its own 'tobacco' moment in court
-
Toyota ex-chief Okuda, pioneer of the Prius, dead at 93
-
Art or medicine? Japan's cosmetic tattoo artists in limbo
-
Colombia rescuers find woman alive as quake death toll passes 200
-
Rybakina ousts Osaka to book Toronto semi-final against Gauff
-
New Zealand PM survives leadership challenge months from election
-
Colombia rescuers find woman alive as quake death toll passes 240
-
Passengers rescued as second ferry in days catches fire in Indonesia
-
Charges dropped against Bondi Beach attack hero
-
Oil prices rise, stocks mixed ahead of crucial US inflation data
-
Parched and desperate for rain, Kazakhstan turns to cloud-seeding
-
UK 'joke' candidate Binface pushes serious point about politics
-
The perfect storm that turbocharged Venezuela's twin quakes
-
New Zealand PM Luxon survives leadership challenge months from election
-
2.4 million girls banned from Afghan schools since Taliban return: UNESCO
-
Cuba celebrates Castro's 100th as his revolution faces its toughest test
-
Colombians dig through rubble as quake death toll surpasses 240
-
Defending champion Shelton rolls into Montreal semis
-
New Zealand's ruling party meets to decide PM Luxon's fate
-
What to know about the total solar eclipse
-
Total solar eclipse to spellbind Europe
-
Tentoglou claims fourth Euro long jump title, injured Jacobs falters
-
Jodar, Nakashima to make Masters semis debuts in Montreal
-
All Blacks knew Nonu would perform solo Haka - coach Rennie
-
Chilean veteran Sanchez signs with MLS club Montreal
-
Britain's Glave upstages Jacobs to win European 100m gold
-
Cristiano Ronaldo marries long-term partner Georgina Rodriguez
-
Greece's Tentoglou wins fourth European long jump title
-
Oil prices higher, stocks mixed ahead of inflation report
-
Doctors ignored 'warning signs' before Maradona's death, court hears
-
Jacobs into 100m final with eye on third title
-
Pereira, the 'zombie city' devastated by Colombia's earthquake
-
Eight-try New Zealand cruise to tour victory over Sharks
-
UN says 2 staff arrested by Afghan intelligence agency
-
Trump's secret plane swap triggers questions and confusion
-
Colombia scrambles to find survivors as quake kills 240
-
California calls Paramount's threat to leave state 'blackmail'
-
Ramsay-Peaty out of medals as Italy's Martinenghi wins European gold
-
PSG 'want to win everything', says Luis Enrique
-
AI firm Manus to resume 'independent' operations after China blocks Meta deal
-
Barred from elections, Russia's anti-war party vows to fight on
-
Caught between great powers: the cautionary tale of Manus
-
Jaissle states Newcastle ambition but urges patience
-
Heatwave hits evicted families sleeping rough in Rome
-
NBA star Cooper Flagg trading card a slam dunk for lucky buyer
-
US company stokes Greenland tensions by unloading drilling gear
-
ForumPay Expands Payment Infrastructure with New Card and Bank Transfer Acceptance Solution
-
Cambridge academic in plagiarism row publishes memoir
-
Oil prices higher, stocks flat ahead of inflation report
-
LeBron's Sixers hope to spoil Knicks party on NBA opening night
Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
A.F.Rosado--PC